Eloxx Pharmaceuticals, Inc. (ELOX)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - - - - - -
Cost of Revenue - - - - - -
Gross Profit - - - - - -
Operating Expenses 34.41 Million 66.01 Million 29.43 Million 50.55 Million 46.97 Million 19.1 Million
Selling, General and Administrative Expenses 10.69 Million 20.44 Million 14.84 Million 24.2 Million 26.48 Million 2.7 Million
Research and Development Expenses 23.72 Million 45.56 Million 14.59 Million 26.34 Million 20.48 Million 16.39 Million
Other Expenses - - - - - -
Cost and Expenses 34.41 Million 66.01 Million 29.43 Million 50.55 Million 46.97 Million 19.1 Million
Operating Income -34.41 Million -66.01 Million -33.45 Million -50.55 Million -47.56 Million -20.39 Million
Interest Expense 1.94 Million 1.25 Million 1.4 Million 1.61 Million 7000.00 43 Thousand
Income Tax Expense - 1.25 Million 1.4 Million 1.61 Million 122 Thousand 43 Thousand
Earnings before Tax -36.06 Million -66.72 Million -34.57 Million -50.87 Million -47.06 Million -21.21 Million
Net Income -36.06 Million -66.72 Million -34.57 Million -50.87 Million -47.18 Million -21.21 Million
Earnings Per Share Basic -16.65 -38.15 -34.47 -53.46 -58.19 -170.52
Earnings Per Share Diluted -16.65 -38.15 -34.47 -53.46 -58.19 -170.52
Weighted Average Shares Outstanding 2.16 Million 1.74 Million 1 Million 951.57 Thousand 810.91 Thousand 124.4 Thousand
Weighted Average Shares Outstanding (Diluted) 2.16 Million 1.74 Million 1 Million 951.57 Thousand 810.91 Thousand 124.4 Thousand
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -33.37 Million -66.01 Million -33.45 Million -50.55 Million -46.15 Million -20.39 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts